HGH Fragment 176-191 + Mod GRF(1-29) – [CJC without DAC] –

Researchers rely on this combination to explore how metabolic pathways and growth-hormone stimulation may interact during mechanistic studies. By pairing a fragment focused on adipocyte signalling with a peptide designed to modulate GH-pulse dynamics, this blend enables deeper experimental insight into coordinated downstream pathways.

Research teams commonly select this blend for:

• Analysing pituitary-driven GH-release timing

• Mapping GH-associated metabolic mechanisms

• Studying adipocyte behaviour in isolated models

• Comparing combination effects with single-peptide controls

Each component in the HGH Fragment 176-191 + Mod GRF(1-29) peptide blend delivers predictable activity in vitro or ex vivo, supporting reproducible results and clean analytical interpretation. The formulation assists with precise dosing and controlled exposure modelling across advanced endocrine and metabolic research workflows.

This peptide blend is supplied as a high-purity laboratory reagent intended only for trained scientific professionals. It is not approved for human or veterinary administration, therapeutic use, clinical application, or diagnostic procedures. All handling must comply with institutional laboratory safety protocols and applicable regulatory guidelines.

For research use only. Not for human consumption.